2021-11-10T19:09:29-07:00 2021-06-30 990 2020-07-01 030485196 MYELIN REPAIR FOUNDATION INC MYEL 20111 Edinburgh Drive Saratoga CA 95070 Scott Johnson Chief Executive Officer 4087610201 2021-11-12 1 11 1 AAL2 X 2020 2022-09-23 18:48:47Z Scott Johnson 20111 Edinburgh Drive Saratoga CA 95070 530327 0 X myelinrepair.org X 2002 CA Accelerating the development of new therapeutics to prevent or repair damage to myelin caused by MS 5 4 1 0 0 0 253579 478580 0 0 11669 699 1400 51048 266648 530327 322993 24964 0 0 156307 139250 0 0 3997 75453 71305 554753 235519 -288105 294808 1357117 1468414 561039 377528 796078 1090886 Accelerating the development of new therapeutics to prevent or repair damage to myelin caused by Multiple Sclerosis. The MRF is helping to identify biomarkers of myelin repair for use in myelin repair drug development and clinical trials 0 0 223323 0 0 We only have one area of program services and that is scientific research to benefit Multiple Sclerosis (MS) patients. Currently our research is focused on experiments to identify biomarkers to indicate repair of myelin damaged by MS. Over the last year, we focused our research on extracellular vesicles(EVs) isolated from blood. We currently have 12 investigations underway spread across Europe and North America. We have encouraging preliminary data showing that we can clearly distinguish MS patient EV's from healthy controls and may be able to identify sub-types of MS. 0 0 0 223323 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 4 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 0 0 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1 0 0 CA X Louise Savoie 4088885542 2198 Hillstone Dr San Jose CA 95138 Scott Johnson CEO 20 0 X X 120000 0 0 Casey Mcglynn Director 1 0 X 0 0 0 Andy Cates Director 1 0 X 0 0 0 Bobby Mehta Director 1 0 X 0 0 0 Jim Gidwitz Director 1 0 X 0 0 0 120000 0 0 1 0 0 0 0 0 0 0 0 0 478580 0 478580 0 699 699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 51048 51048 0 0 51048 530327 51747 0 0 X 24964 24964 0 0 0 0 120000 120000 9636 6263 1735 1638 9614 6250 1731 1633 3965 3965 59950 59950 4266 2772 768 726 3124 3124 235519 223323 8199 3997 123943 314692 846080 846722 387000 307000 94 1357117 1468414 540117 356606 20922 20922 561039 377528 X 796078 1090886 0 0 796078 1090886 1357117 1468414 294808 0 0 0 0 0 X 0 0 0 X 50000 1007500 287392 253579 478580 2077051 50000 1007500 287392 253579 478580 2077051 1006510 1070541 6926 11669 699 19294 70054 51048 121102 2217447 0 0.48278 0.38557 X Schedule A, Part II, Line 10 Refund due to cancelled Sponsored Research Agreement and refund of worker's compensation from prior year RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 Oregon Health & Science University Research Development Sponsored 0690 SW Bancroft St Portland OR 97239 931176109 24964 0 contractual amount 1 0 Schedule I, Part I, Line 2 The Universities are subject to terms and conditions of the sponsored research agreement between the Universities and the MRF. The researchers' work is reviewed by the MRF Scientific Director, Executive Committee and by the MRF president. Form 990, Part VI, Section A, Line 9 These are the home address's for the board members. Andy's and Casey's are work addresses. 1. Andy Cates 429 N. Main Street, suite 100, Memphis, TN 38103 2. Jim Gidwitz 440 S. LaSalle, suite 3100, Chicago, IL 60605-5020 3. Casey McGlynn 650 Page Mill Road, Palo Alto, CA 94304-1001 4.Bobby Mehta 159 E. Walton Street, Chicago, IL 60611 Form 990, Part VI, Section B, Line 11b Form 990 is reviewed by the CEO and once the CEO approves, it is then forwarded to the board members for their review prior to filing. Board members are encouraged to review and forward their questions, if any, to the CEO. Form 990, Part VI, Section B, Line 12c Officers, directors, and key employees are covered. Any and all conflicts are reviewed by disinterested board members and, if needed, by legal counsel. Persons with a conflict of interest will be restricted from making key decisions for MRF as they relate to the interest unless otherwise approved by the majority of the disinterested board of directors. Form 990, Part VI, Section B, Line 15 Compensation is determined by the board of directors Form 990, Part VI, Section C, Line 19 Financial Statements, governing documents and policies are available upon request for the same period of time set forth in Sec.6104(D) Form 990, Part IX, Line 11g General Consulting